References from scientific journals

Acitretin Use in Dermatology.

Guenther LC, Kunynetz R, Lynde CW, Sibbald RG, Toole J, Vender R, Zip C. Guenther LC, et al. J Cutan Med Surg. 2017 Nov/Dec;21(3_suppl):2S-12S. doi: 10.1177/1203475417733414. Epub 2017 Sep 27. J Cutan Med Surg. 2017. PMID: 28952335 Review.

BACKGROUND: Acitretin has been used for the treatment of severe psoriasis for over 20 years. ...METHODS: A literature review was conducted to explore the role of acitretin and to assess its value for dermatologic disorders other than severe psoriasis. ...
BACKGROUND: Acitretin has been used for the treatment of severe psoriasis for over 20 years. ...METHODS: A literature review was cond …

Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects.

Raposo I, Torres T. Raposo I, et al. Am J Clin Dermatol. 2016 Aug;17(4):349-58. doi: 10.1007/s40257-016-0191-7. Am J Clin Dermatol. 2016. PMID: 27113059 Review.

Classical management of mild to moderate palmoplantar pustulosis and palmoplantar psoriasis relies on use of potent topical corticosteroids, phototherapy, and/or acitretin. Nevertheless, these drugs have proven to be insufficient in long-term control of extensive disease. …
Classical management of mild to moderate palmoplantar pustulosis and palmoplantar psoriasis relies on use of potent topical corticosteroids, …

Drugs for discoid lupus erythematosus.

Jessop S, Whitelaw DA, Grainge MJ, Jayasekera P. Jessop S, et al. Cochrane Database Syst Rev. 2017 May 5;5(5):CD002954. doi: 10.1002/14651858.CD002954.pub3. Cochrane Database Syst Rev. 2017. PMID: 28476075 Free PMC article. Review.

The main adverse effects were dry lips (93% of the acitretin group and 20% of the hydroxychloroquine group) and gastrointestinal disturbance (11% of the acitretin group and 17% of the hydroxychloroquine group). ...AUTHORS' CONCLUSIONS: Fluocinonide cream may be more …
The main adverse effects were dry lips (93% of the acitretin group and 20% of the hydroxychloroquine group) and gastrointestinal dist …

Acitretin.

Tan MG, Shear NH, Walsh S, Alhusayen R. Tan MG, et al. J Cutan Med Surg. 2017 Jan/Feb;21(1):48-53. doi: 10.1177/1203475416659858. Epub 2016 Jul 19. J Cutan Med Surg. 2017. PMID: 27432818

All patients had failed other standard systemic medications prior to initiating acitretin. Six patients (43%) received acitretin monotherapy, and 8 patients (57%) received acitretin as an adjuvant to other standard systemic medications. ...Acitretin ma …
All patients had failed other standard systemic medications prior to initiating acitretin. Six patients (43%) received acitretin …

[Acitretin].

Sbidian E; Groupe de recherche sur le psoriasis de la Société française de dermatologie. Sbidian E, et al. Ann Dermatol Venereol. 2019 Jun-Jul;146(6-7):454-458. doi: 10.1016/j.annder.2019.04.008. Epub 2019 Jun 20. Ann Dermatol Venereol. 2019. PMID: 31229350 French. No abstract available.


Acitretin.

Ortiz NE, Nijhawan RI, Weinberg JM. Ortiz NE, et al. Dermatol Ther. 2013 Sep-Oct;26(5):390-9. doi: 10.1111/dth.12086. Dermatol Ther. 2013. PMID: 24099069

Acitretin, a synthetic retinoid, is the pharmacologically active metabolite of etretinate. ...Acitretin is limited by its teratogenicity and therefore considered inappropriate in most female patients of childbearing age. ...
Acitretin, a synthetic retinoid, is the pharmacologically active metabolite of etretinate. ...Acitretin is limited by its tera …

[Acitretin].

Dubertret L. Dubertret L. Ann Dermatol Venereol. 2011 Dec;138(12):829-32. doi: 10.1016/j.annder.2011.10.001. Epub 2011 Nov 5. Ann Dermatol Venereol. 2011. PMID: 22137620 French. No abstract available.


[Acitretine].

Berbis P. Berbis P. Ann Dermatol Venereol. 2001 Jun-Jul;128(6-7):737-45. Ann Dermatol Venereol. 2001. PMID: 11460037 Free article. Review. French.

Acitretin (Soriatane(R)) is an aromatic retinoid (carboxylic acid metabolite of etretinate). Acitretin has a terminal elimination half-life of about 55 to 60 hours. ...
Acitretin (Soriatane(R)) is an aromatic retinoid (carboxylic acid metabolite of etretinate). Acitretin has a terminal eliminat …

[Acute pancreatitis under acitretin].

Bahtaoui W, El Fetoiki FZ, Hali F, Chiheb S. Bahtaoui W, et al. Ann Dermatol Venereol. 2020 Sep;147(8-9):530-534. doi: 10.1016/j.annder.2020.01.015. Epub 2020 Feb 11. Ann Dermatol Venereol. 2020. PMID: 32057450 French.

Acute pancreatitis is a rare adverse effect of systemic retinoids. We report a case occurring during acitretin treatment for psoriasis. PATIENTS AND METHODS: A 27-year-old male patient with no history of diabetes, obesity, alcohol consumption or medication consulted for ex …
Acute pancreatitis is a rare adverse effect of systemic retinoids. We report a case occurring during acitretin treatment for psoriasi …

Napsi.

Tchornobay AM. Tchornobay AM. An Bras Dermatol. 2012 Sep-Oct;87(5):805; author reply 806. doi: 10.1590/s0365-05962012000500030. An Bras Dermatol. 2012. PMID: 23044586 No abstract available.